Bioregenx, Inc. (BRGX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

959.71M
Year ended 2025-12-31
2021-12-31: 269.75M2022-12-31: 269.75M2023-12-31: 639.78M2024-12-31: 912.37M2025-12-31: 959.71M959.71M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31959.71M+5.2%2026-04-15, From 2025-01-01
2024-12-31912.37Mn/c2026-04-15, From 2024-01-01
2023-12-31639.78M+137.2%2025-04-16, From 2023-01-01
2022-12-31269.75M0.0%2024-04-12, From 2022-01-01
2021-12-31269.75Mn/a2023-04-04, From 2021-01-01